SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 100 filers reported holding SCICLONE PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,127,000 | +22.4% | 100,634 | +20.2% | 0.00% | +100.0% |
| Q2 2017 | $921,000 | +16.1% | 83,700 | +3.5% | 0.00% | 0.0% |
| Q1 2017 | $793,000 | -20.1% | 80,900 | -12.0% | 0.00% | -50.0% |
| Q4 2016 | $993,000 | -25.1% | 91,900 | -28.9% | 0.00% | 0.0% |
| Q3 2016 | $1,325,000 | -25.0% | 129,300 | -4.4% | 0.00% | -33.3% |
| Q2 2016 | $1,766,000 | +16.3% | 135,200 | -2.1% | 0.00% | +50.0% |
| Q1 2016 | $1,519,000 | -32.0% | 138,100 | -43.1% | 0.00% | -50.0% |
| Q4 2015 | $2,235,000 | +10.2% | 242,900 | -16.9% | 0.00% | +33.3% |
| Q3 2015 | $2,028,000 | -30.1% | 292,200 | -1.2% | 0.00% | -25.0% |
| Q2 2015 | $2,903,000 | +24.8% | 295,600 | -6.4% | 0.00% | +33.3% |
| Q1 2015 | $2,327,000 | 0.0% | 315,800 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $2,327,000 | +25.0% | 315,800 | +16.9% | 0.00% | 0.0% |
| Q3 2014 | $1,861,000 | +112.2% | 270,100 | +61.9% | 0.00% | +200.0% |
| Q2 2014 | $877,000 | +15.4% | 166,800 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $760,000 | +41.3% | 166,800 | +63.0% | 0.00% | 0.0% |
| Q4 2013 | $538,000 | +1.3% | 102,300 | -2.3% | 0.00% | 0.0% |
| Q3 2013 | $531,000 | -0.6% | 104,700 | -2.7% | 0.00% | 0.0% |
| Q2 2013 | $534,000 | – | 107,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|